- Extremely Elevated International Normalized Ratio of Warfarin in a Patient with CYP2C9*1/*3 and Thyrotoxicosis
-
Lee JE, Ryu DH, Jeong HJ, Kim JH, Jun JE, Kim JS, Lee SY
- KMID: 1794613
- J Korean Med Sci.
- 2014 Sep;29(9):1317-1319.
- doi: 10.3346/jkms.2014.29.9.1317
A 73-yr-old Korean man with permanent atrial fibrillation visited outpatient clinic with severely increased International Normalized Ratio (INR) values after taking a usual starting dosage of warfarin to prevent thromboembolism.... -
- CITED
-
- Close
- SHARE
-
- Close
- Development and Comparison of Warfarin Dosing Algorithms in Stroke Patients
-
Cho SM, Lee KY, Choi JR, Lee KA
- KMID: 2374082
- Yonsei Med J.
- 2016 May;57(3):635-640.
- doi: 10.3349/ymj.2016.57.3.635
PURPOSE: The genes for cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase complex subunit 1 (VKORC1) have been identified as important genetic determinants of warfarin dosing and have been... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Pharmacogenetic Testing and Application: Laboratory Medicine Clinical Practice Guidelines
-
Kim S, Yun YM, Chae HJ, Cho HJ, Ji M, Kim IS, Wee KA, Lee W, Song SH, Woo HI, Lee SY, Chun S
- KMID: 2373642
- Ann Lab Med.
- 2017 Mar;37(2):180-193.
- doi: 10.3343/alm.2017.37.2.180
Pharmacogenetic testing for clinical applications is steadily increasing. Correct and adequate use of pharmacogenetic tests is important to reduce unnecessary medical costs and adverse patient outcomes. This document contains recommended... -
- CITED
-
- Close
- SHARE
-
- Close
